• Aucun résultat trouvé

Prise de position de l’Académie : Pour un renfort vétérinaire au diagnostic du Covid-19 – Académie nationale de médecine

N/A
N/A
Protected

Academic year: 2022

Partager "Prise de position de l’Académie : Pour un renfort vétérinaire au diagnostic du Covid-19 – Académie nationale de médecine"

Copied!
1
0
0

Texte intégral

(1)

For a veterinary help to the Covid-19 diagnosis Position of the French National Academy of Medicine

March 30, 2020

The French National Academy of Medicine supports the position expressed by the French Veterinary Academy in its press release of March 28, 2020 on Covid-19 tests. The two Academies put into practice the "One Health" concept advocated by international organisations such as the Word Health Organisation and the World Organisation for Animal Health, by consulting on the responses to be provided in the current pandemic situation.

In several Member States of the European Union (Germany, Belgium, Italy...), producers of veterinary reagents are authorised to manufacture Covid-19 diagnostic kits and veterinary laboratories can use them for human diagnosis. Manufacturers of large-scale diagnostic tests are accredited for many pathogens, including animal coronaviruses, and offer full guarantees of safety. In addition, veterinary laboratories accredited for the diagnosis of animal diseases, some of which are zoonotic, are able to carry out Covid-19 diagnosis in humans with the same guaranteed performance as Medical Biology Laboratories.

The French National Academy of Medicine therefore recommends that in France too, the Health Authorities issue an exceptional authorisation to these manufacturers and laboratories in the veterinary sector in the context of the current health emergency. This would be an invaluable contribution to controlling the Covid-19 epidemic in France.

Références

Documents relatifs

L’atteinte cérébrale peut être liée au virus ou résulter d’une anoxie chez les malades ventilés, d’accidents vasculaires cérébraux, ou d’une encéphalomyélite

Brain damage may be related to the virus or may result from anoxia in ventilated patients, strokes or acute disseminated autoimmune encephalomyelitis which, if it affects the

déconseille formellement l’utilisation inconsidérée de tisanes ou décoctions à base d’Artemisia, sous quelque forme que ce soit, pour le traitement de la Covid-19, tant

Considering that the difficulty of conducting a clinical study to prove the efficacy of herbal medicine in the treatment of Covid-19 does not allow to bypass

- recommande de doser rapidement le taux de vitamine D sérique (c’est-à-dire la 25 OHD) chez les personnes âgées de plus de 60 ans atteintes de Covid-19, et

Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: a position statement of the European Calcified

de s’assurer que les patients porteurs d’une affection psychiatrique chronique (schizophrénie, bipolarité...) et suspects de Covid-19 bénéficient d’une

to ensure that patients with a chronic psychiatric condition (schizophrenia, bipolarity, etc.) and suspected of Covid-19 benefit from effective monitoring at home and